GHRP-2
Growth Hormone Releasing Peptide-2
GHRP-2 (Growth Hormone Releasing Peptide-2), also known as pralmorelin, is a synthetic hexapeptide that acts as a potent agonist at the ghrelin/growth hormone secretagogue receptor (GHS-R). It triggers pulsatile growth hormone release from the pituitary gland, mimicking the body's natural GH secretion patterns. GHRP-2 was developed as a diagnostic agent and is clinically approved in Japan for assessing growth hormone deficiency. Unlike direct GH administration, GHRP-2 works through the body's natural pathways, making it a preferred option for those seeking to enhance their natural growth hormone production safely and effectively.
Complete Dosing Guide
Administration Guidelines
Injection Sites
- Subcutaneous injection into abdomen, thigh, or deltoid
- Use insulin syringe (29-31 gauge)
- Clean injection site with alcohol swab
- Inject slowly over 5-10 seconds
Rotation Schedule
- Rotate injection sites to prevent lipodystrophy
- Apply gentle pressure after removal
- Allow injection site to reach room temperature before injection
Timing
- Administer on empty stomach (1 hour before or 2 hours after meals)
- Morning dose: Upon waking
- Post-workout dose: Immediately after training
- Bedtime dose: 30-60 minutes before sleep
Medical Disclaimer
Clinical data presented is from peer-reviewed studies. Individual results may vary. Consult healthcare professionals before starting treatment. This information is for educational purposes only.